Cigna (CI) EBITDA (2017 - 2026)

Cigna has disclosed EBITDA across 10 years of filings, most recently posting $202.0 million for Q1 2026.

• EBITDA for Q1 2026 came in at $202.0 million, down 15.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 43.18% YoY), and the FY2025 annual result was $9.2 billion, down 2.3% from the prior year.
• EBITDA came in at $202.0 million for Q1 2026 at Cigna, down from $2.3 billion in the prior quarter.
• In the past five years, EBITDA ranged from a high of $7.7 billion in Q4 2023 to a low of $202.0 million in Q1 2026.
• The 5-year median for EBITDA is $321.0 million (2023), against an average of $1.4 billion.
• Across the five-year window, EBITDA soared 714.44% in 2024 and tumbled 90.95% in 2025, its largest moves.
• Cigna's EBITDA stood at $1.7 billion in 2022, then jumped by 337.96% to $7.7 billion in 2023, then tumbled by 71.63% to $2.2 billion in 2024, then climbed by 7.92% to $2.3 billion in 2025, then sank by 91.39% to $202.0 million in 2026.
• The last three EBITDA figures came in at $202.0 million (Q1 2026), $2.3 billion (Q4 2025), and $233.0 million (Q3 2025), per Business Quant data.